Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.

Toshiaki OhkumaLuc Van GaalWayne ShawKenneth W MahaffeyDick de ZeeuwDavid R MatthewsVlado PerkovicBruce C Neal

Published in: Diabetes, obesity & metabolism (2020)

Canagliflozin improved cardiovascular and renal outcomes consistently across patients with a broad range of BMI levels.

Keyphrases